daniel lavanchy
daniel lavanchy
healthcare consultant
Verified email at alumnibasel.ch
TitleCited byYear
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
Journal of viral hepatitis 11 (2), 97-107, 2004
31852004
The global burden of hepatitis C
D Lavanchy
Liver international 29, 74-81, 2009
16762009
Evolving epidemiology of hepatitis C virus
D Lavanchy
Clinical Microbiology and Infection 17 (2), 107-115, 2011
15092011
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
C Frank, MK Mohamed, GT Strickland, D Lavanchy, RR Arthur, ...
The Lancet 355 (9207), 887-891, 2000
13572000
EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ...
Journal of Hepatology 39 (SUPPL. 1), 2003
665*2003
EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ...
Journal of Hepatology 39 (SUPPL. 1), 2003
665*2003
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention
D Lavanchy
Journal of clinical virology 34, S1-S3, 2005
6282005
EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ...
Journal of Hepatology 39 (SUPPL. 1), 2003
5302003
EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ...
Journal of Hepatology 39 (SUPPL. 1), 2003
5302003
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The Lancet Gastroenterology & Hepatology 2 (3), 161-176, 2017
4972017
Global burden of disease (GBD) for hepatitis C
Global Burden of Hepatitis C Working Group
The Journal of Clinical Pharmacology 44 (1), 20-29, 2004
4302004
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
4002014
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium
World Health Organization
J Viral Hepat 6, 35-47, 1999
3401999
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ...
Journal of viral hepatitis 21, 5-33, 2014
2852014
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ...
Journal of viral hepatitis 21, 60-89, 2014
2082014
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
D FitzSimons, G François, A Hall, B McMahon, A Meheus, A Zanetti, ...
Vaccine 23 (32), 4158-4166, 2005
1602005
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002. Geneva, Switzerland. Consensus statement (short version)
E Jury
J Hepatol 38, 533-540, 2003
1592003
WHO report on global surveillance of epidemic-prone infectious diseases
World Health Organization
World Health Organization, 2000
1592000
Hepatitis B virus infection in dentistry: a forgotten topic
N Mahboobi, F Agha‐Hosseini, N Mahboobi, S Safari, D Lavanchy, ...
Journal of viral hepatitis 17 (5), 307-316, 2010
1342010
Chronic viral hepatitis as a public health issue in the world
D Lavanchy
Best practice & research Clinical gastroenterology 22 (6), 991-1008, 2008
1342008
The system can't perform the operation now. Try again later.
Articles 1–20